Posts Tagged ‘Orion’

The European Investment Bank (EIB) is lending €100 million to Finnish pharmaceutical company Orion Pharma to develop new treatments for cancer, pain and other serious conditions with few treatment options.

The financing will support Orion Pharma’s research and development activities across its European centres, covering personnel costs, clinical trials, patenting and investments in specialised laboratory equipment. By reinforcing Orion Pharma’s long-term R&D capacity, the EIB is helping strengthen Europe’s competitiveness in advanced biopharmaceutical innovation.

Read full announcement (external link)

Originally published on 15 Apr